Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in...
With today’s announcement of the transaction completion, Grifols and Haier Group will work together through...
With Biotest-developed Yimmugo, Grifols adds to its remarkable franchise of intravenous and subcutaneous...
The addition of the Clayton site in 2011 marked a new milestone for Grifols, turning the company into a...
Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of...
In the AdFIrst study, Biotest's fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.